PT1131087E - Metodos de alivio de sintomas de cancro - Google Patents

Metodos de alivio de sintomas de cancro

Info

Publication number
PT1131087E
PT1131087E PT99958892T PT99958892T PT1131087E PT 1131087 E PT1131087 E PT 1131087E PT 99958892 T PT99958892 T PT 99958892T PT 99958892 T PT99958892 T PT 99958892T PT 1131087 E PT1131087 E PT 1131087E
Authority
PT
Portugal
Prior art keywords
bmp
relief
methods
cancer symptoms
gdf
Prior art date
Application number
PT99958892T
Other languages
English (en)
Inventor
Charles M Cohen
David C Rueger
Kuber T Sampath
Original Assignee
Curis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22704676&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1131087(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Curis Inc filed Critical Curis Inc
Publication of PT1131087E publication Critical patent/PT1131087E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
PT99958892T 1998-11-13 1999-11-12 Metodos de alivio de sintomas de cancro PT1131087E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19123998A 1998-11-13 1998-11-13

Publications (1)

Publication Number Publication Date
PT1131087E true PT1131087E (pt) 2004-12-31

Family

ID=22704676

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99958892T PT1131087E (pt) 1998-11-13 1999-11-12 Metodos de alivio de sintomas de cancro

Country Status (10)

Country Link
EP (2) EP1435243A3 (pt)
JP (2) JP4892131B2 (pt)
AT (1) ATE275416T1 (pt)
AU (1) AU1616700A (pt)
CA (1) CA2349038C (pt)
DE (1) DE69920033T3 (pt)
DK (1) DK1131087T4 (pt)
ES (1) ES2226467T5 (pt)
PT (1) PT1131087E (pt)
WO (1) WO2000029012A2 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026713A1 (de) * 2000-05-30 2001-12-06 Walter Sebald Mutein einer Kette eines Proteins aus der Superfamilie des Wachstumsfaktors TGF-beta
ES2390531T3 (es) * 2001-09-18 2012-11-13 Genentech, Inc. Composiciones y procedimientos para el diagnósitco y tratamiento de tumor
JP2008500816A (ja) * 2004-03-31 2008-01-17 ゼンコー・インコーポレイテッド 改善された性質を有するｂｍｐ−７変異体
ES2339132T7 (es) * 2004-08-10 2012-03-16 Cardiff Biologicasl Limited Metodos y kit para el pronostico de cancer de mama.
EP1802326A2 (en) * 2004-09-09 2007-07-04 Stryker Corporation Methods for treating bone tumors using bone morphogenic proteins
JP2008169116A (ja) * 2005-04-18 2008-07-24 Tokyo Medical & Dental Univ Ｂｍｐ−７を含む抗ｃ型肝炎ウイルス剤
ES2642591T3 (es) 2005-05-27 2017-11-16 Bbs-Bioactive Bone Substitutes Oy Proteína morfogenética ósea 3 y dispositivos osteogénicos y productos farmacéuticos que contienen la misma
WO2006125868A1 (en) 2005-05-27 2006-11-30 Bbs-Bioactive Bone Substitutes Oy Bone morphogenetic proteins containing a heparin binding site and osteogenic devices and pharmaceutical products containing thereof
EP1885750B1 (en) 2005-05-27 2011-08-17 BBS - Bioactive Bone Substitutes Oy Bone morphogenetic protein 4 and osteogenic devices and pharmaceutical products containing thereof
DK1904093T3 (en) * 2005-07-19 2018-09-03 Stemgen S P A Inhibition of Tumor-rich Potential of Tumor Stem Cells with BMP-4
GB0615129D0 (en) * 2006-07-29 2006-09-06 Univ Cardiff Anti-cancer activity of BMP-9 and BMP-10 and their use in cancer therapies

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652118A (en) † 1991-03-11 1997-07-29 Creative Biomolecules, Inc. Nucleic acid encoding a novel morphogenic protein, OP-3
US5739107A (en) * 1991-03-11 1998-04-14 Creative Biomolecules, Inc. Morphogen treatment of gastrointestinal ulcers
EP0575555B1 (en) † 1991-03-11 2001-07-18 Curis, Inc. Protein-induced morphogenesis
US6287816B1 (en) * 1991-06-25 2001-09-11 Genetics Institute, Inc. BMP-9 compositions
PT653942E (pt) † 1992-07-31 2003-11-28 Curis Inc Regeneracao e reparacao de nervos induzidos por morfogenios
EP0680334B1 (en) * 1992-09-15 2000-12-13 Creative Biomolecules, Inc. Morphogen treatment of gastrointestinal ulcers
JPH10511840A (ja) † 1994-04-29 1998-11-17 クリエイティブ バイオモレキュールズ，インコーポレイテッド 形態形成タンパク質特異細胞表面レセプターおよびその使用
JPH08225454A (ja) * 1995-02-23 1996-09-03 Chugai Pharmaceut Co Ltd マイクロスフェア製剤
FR2737501B1 (fr) * 1995-07-31 1997-10-24 Transgene Sa Nouveaux virus auxiliaires pour la preparation de vecteurs viraux recombinants
WO1997011095A1 (en) † 1995-09-21 1997-03-27 The Trustees Of Columbia University In The City Of New York Uses of bone morphogenetic proteins
WO1998050061A1 (en) * 1997-05-07 1998-11-12 Biogen, Inc. Novel therapies for cystic kidney disease

Also Published As

Publication number Publication date
WO2000029012A2 (en) 2000-05-25
EP1131087B2 (en) 2009-04-01
JP2010150278A (ja) 2010-07-08
EP1435243A2 (en) 2004-07-07
EP1131087A2 (en) 2001-09-12
DK1131087T3 (da) 2004-12-13
ES2226467T3 (es) 2005-03-16
JP4892131B2 (ja) 2012-03-07
ATE275416T1 (de) 2004-09-15
DE69920033D1 (de) 2004-10-14
DE69920033T2 (de) 2005-09-22
CA2349038C (en) 2011-08-02
AU1616700A (en) 2000-06-05
EP1435243A3 (en) 2005-02-09
WO2000029012A3 (en) 2000-11-16
JP2002529513A (ja) 2002-09-10
WO2000029012A8 (en) 2001-01-11
DK1131087T4 (da) 2009-08-03
ES2226467T5 (es) 2009-08-27
DE69920033T3 (de) 2009-10-08
EP1131087B1 (en) 2004-09-08
CA2349038A1 (en) 2000-05-25

Similar Documents

Publication Publication Date Title
CA2170700A1 (en) Pyrazolopyrimidines and Pyrrolopyrimidines for Treatment of Neuronal and Other Disorders
PT1131087E (pt) Metodos de alivio de sintomas de cancro
CY2436B1 (en) Medicament for treating cardiac inflammatory disease.
MX9602683A (es) Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas.
MX9605023A (es) Compuestos substituidos de imidazolidin-2,4-diona como substancias farmaceuticamente activas.
BR0111892A (pt) Bis-arilsulfonas
WO1997003188A3 (de) Verwendung von mp52 oder mp121 zur behandlung und prävention von erkrankungen des nervensystems
CA2450787A1 (en) Active ingredient combination for pharmacological addictive substance or intoxicant therapy
CA2167004A1 (en) Agent for treating mental disorders associated with cerebrovascular disorders
ES2180774T3 (es) La utilizacion de triacetato de glicerilo para el tratamiento de onicomicosis.
DE60128100D1 (de) Analgetisches arzneimittel
IT1290781B1 (it) Agente attivo terapeutico per il trattamento di malattie degenerative neuronali.
NO20032762L (no) Aktivitetsstyringsanordning
AP9400647A0 (en) Medicaments for use in treatment of HIV or cancer patients.
WO2002099422A3 (en) Individualization of therapy with alzheimer's disease agents
CA2153778A1 (en) Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states
Font et al. Finding the words: Instruments for a therapy of liberation
Coppola et al. Early retroduodenal perforation following endoscopic internal biliary drainage
BR9910185A (pt) Uso de um composto, e, processo para o tratamento de um paciente que sofre de, ou em risco de, uma doença micobacteriana
AU1875395A (en) 4-amino derivatives of 5-substituted mycophenolic acid
CA2197176A1 (en) Use of selegiline for the treatment of epileptic disorders
MY132436A (en) Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases
CA2452432A1 (en) Active ingredient combination for the pharmacological therapy of nicotine dependence
BR0017035A (pt) Combinação de trimebutina com um analgésico opióide
IT240104Y1 (it) Dispositivo per il trattamento del corpo umano.